Contact this trialFirst, we need to learn more about you.
Dopamine D1 Receptor Antagonist
Ecopipam for Tourette Syndrome
Recruiting1 awardPhase 3
Ajax, Ontario
This trial tests ecopipam tablets in people with Tourette's Disorder. The medication aims to reduce tics by blocking certain brain signals. Ecopipam is being tested for its safety and tic-reducing activity in adults with Tourette syndrome.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service